|
BIOTECH Patent News
BIOTECH Patent News provides a roundup of timely information on patented and patent-pending biotechnology breakthroughs and joint ventures.
ProteoTech obtains patent covering treatments for human amyloid diseas...
October 01, 2003
Hybridon obtains patent for second generation antisense oligonucleotid...
October 01, 2003
Dana-Farber, Phosphoproteomics, Cell Signaling Technology agree on pho...
October 01, 2003
Rib-X Pharmaceuticals receives patent for bacteria technology.
October 01, 2003
Progen granted anti-angiogenesis antibody patent.
October 01, 2003
Chiron grants non-exclusive HCV license to Pfizer.
October 01, 2003
Nanogen licenses rights to gene linked to hereditary deafness.
October 01, 2003
Micro Therapeutics announces Dutch Court patent decision.(Brief Articl...
October 01, 2003
Paradigm Genetics receives patent for fungicide target.
October 01, 2003
Benitec achieves breakthrough in gene silencing.
October 01, 2003
Ribonomics obtains United States patent covering methods for obtaining...
October 01, 2003
Pharmacopeia forms drug screening collaboration.
October 01, 2003
Paradigm Genetics and Affymetrix sign microarray technology agreements...
October 01, 2003
Affymetrix and bioMerieux expand infectious disease collaboration.
October 01, 2003
diaDexus forms diagnostic license agreements with Human Genome Science...
October 01, 2003
Primagen and Delphic form toxicity assay distribution and licensing ag...
October 01, 2003
Patent awarded for pancreatic enzyme therapy for ADD.
October 01, 2003
Abgenix and Amgen clarify responsibilities for epidermal growth factor...
October 01, 2003
Bayer CropScience and Monsanto reach agreement providing farmers with ...
October 01, 2003
Chiron announces settlement of patent dispute over tobramycin solution...
October 01, 2003
VaxGen finalizes commercial rights to anthrax vaccine.
October 01, 2003
European Patent Office affirms revocation of Serono gene.
October 01, 2003
Bolder BioTechnology receives United States patent for modified human ...
October 01, 2003
Immune Response licenses Hybridon's AMPLIVAX vaccine adjuvant.
October 01, 2003
Cosmix Molecular Biologicals obtains United States patent.(Brief Artic...
October 01, 2003
National Science Foundation obtains United States patent.(Brief Articl...
October 01, 2003
Merck obtains United States patent.(Brief Article)
October 01, 2003
Council of Scientific & Industrial Research obtains United States pate...
October 01, 2003
International Reagents obtains United States patent.(Brief Article)
October 01, 2003
Salk Institute obtains United States patent.(Salk Institute for Biolog...
October 01, 2003
University of Tennessee obtains United States patent.(University of Te...
October 01, 2003
Max-Planck obtains United States patent.(Max-Planck-Gesellschaft zur F...
October 01, 2003
Toyo Boseki obtains United States patent.(Brief Article)
October 01, 2003
Aventis obtains United States patent.(Aventis Pharmaceuticals)(Brief A...
October 01, 2003
Plant Bioscience obtains United States patent.(Brief Article)
October 01, 2003
HSP Research Institute obtains United States patent.(Brief Article)
October 01, 2003
Diversa obtains United States patent.(Brief Article)
October 01, 2003
Centre National de la Recherche Scientific obtains United States paten...
October 01, 2003
|
